Cover Image
Market Research Report

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies

Published by Visiongain Ltd Product code 752340
Published Content info 229 Pages
Delivery time: 1-2 business days
Price
Back to Top
Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies
Published: October 3, 2018 Content info: 229 Pages
Description

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 229-page report you will receive 132 charts- all unavailable elsewhere.

The 229-page report provides clear detailed insight into the leading pharmaceutical wholesale & distribution organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027.

Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027 segmented by submarket:

  • Branded Drugs
  • Generic Drugs
  • Others

A SWOT and STEP analysis of the global pharmaceutical wholesale & distribution market

Profiles of the 20 leading pharmaceutical wholesale & distribution organizations:

  • Alfresa Holdings
  • AmerisourceBergen
  • Anda Inc.
  • Cardinal Health
  • CR Pharmaceutical
  • CuraScript Special
  • Fortissa Limited
  • H.D. Smith
  • Mawdsley-Brooks & Co. Ltd.
  • McKesson
  • MEDIPAL HOLDINGS
  • Morris & Dickson Co. LLC
  • North Carolina Mutual Wholesale Drug
  • Prodigy Health
  • Shanghai Pharmaceutical Holdings.
  • SINOPHARM
  • Smith Drug Company
  • SUZUKEN
  • The PHOENIX Group
  • Walgreens Boots AllianceSUZUKEN
  • The PHOENIX Group
  • Walgreens Boots Alliance

The content of each profile differs, depending on the organization. In general, a profile gives the following information:

  • Overview of the company's services and operations
  • Analysis of recent financial performance - annual revenue for services, including data on operating profit and margins
  • Assessment of developments - activities, acquisitions, production capacity, deals, new service offerings and collaborations

Visiongain's study is intended for anyone requiring commercial analyses for pharmaceutical wholesale & distribution market. You find data, trends and predictions.

Buy our report today Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies.

Visiongain is a trading partner with the US Federal Government

Table of Contents
Product Code: PHA0335

Table of Contents

1. Report Overview

  • 1.1. Global Pharma Wholesale and Distribution Industry and Market Overview
  • 1.2. How This Report Delivers
  • 1.3. Questions Answered by This Analytical Report
  • 1.4. Who is This Report For?
  • 1.5. Methodology
  • 1.6. Frequently Asked Questions (FAQ)
  • 1.7. Associated Visiongain Reports
  • 1.8. About Visiongain

2. Introduction to Pharma Wholesale and Distribution

  • 2.1. The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
    • 2.1.1. Full-Line Wholesalers (FLWs)
    • 2.1.2. Short-Line Wholesalers (SLWs)
  • 2.2. The Chain of Distribution: Wholesalers vs. Logistic Service Providers
    • 2.2.1. Secondary Wholesalers
    • 2.2.2. Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
    • 2.2.3. Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits
    • 2.2.4. Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
    • 2.2.5. Pharmacy Benefit Managers
  • 2.3. Generative Revenue and Profit
    • 2.3.1. Forward Buying to Avoid Price Increases
    • 2.3.2. Fee-for-Service: A Clear Pricing Structure
      • 2.3.2.1. Inventory Management Agreements
    • 2.3.3. Discounts: Incentives for Prompt Payment or Bulk Purchases
    • 2.3.4. Reimbursement and Wholesalers
    • 2.3.5. Clawback: The Recovery of Reimbursement Costs by Governments
    • 2.3.6. Parallel Trade: Different Attitudes in Europe and the US

3. The World Pharmaceutical Wholesale and Distribution Market: 2016-2027

  • 3.1. The World Pharmaceutical Wholesale and Distribution Market in 2016, Restricted by Government Price Reductions and Generic Substitution
  • 3.2. The Pharmaceutical Wholesale and Distribution Industry: World Market Forecast, 2016-2027
  • 3.3. Branded and Generic Drugs: Revenue vs. Profit, 2016-2027
    • 3.3.1. Branded and Generic Drugs: Revenue Generation, 2016
    • 3.3.2. Branded Drugs: Revenue Forecast, 2016-2027
    • 3.3.3. Generic Drugs: Revenue Forecast, 2016-2027

4. Leading Pharma Wholesalers and Distributors In 2018: Current and Future Performance

  • 4.1. McKesson: The Oldest and Largest Healthcare Services Company in the US
    • 4.1.1. McKesson: Historical Performance, 2007-2017
    • 4.1.2. Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
    • 4.1.3. McKesson: Revenue Forecast, 2018-2028
  • 4.2. Cardinal Health: The World's Third Largest Pharma Wholesaler
    • 4.2.1. Cardinal Health: Historical Performance, 2010-2017
    • 4.2.2. Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
    • 4.2.3. Cardinal Health: Revenue Forecast, 2018-2028
  • 4.3. AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
    • 4.3.1. AmerisourceBergen: Historical Performance, 2018
    • 4.3.2. Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
    • 4.3.3. AmerisourceBergen: Revenue Forecast, 2018-2028
  • 4.4. Walgreens Boots Alliance: The Largest Drugstore Chain in the US and Global Wholesale and Distribution Network
    • 4.4.1. Walgreens Boots Alliance: Historical Performance, 2011-2017
    • 4.4.2. Acquisitions and Future Strategies of Walgreens Boots Alliance
    • 4.4.3. Walgreens Boots Alliance: Revenue Forecast, 2018-2028
  • 4.5. MEDIPAL HOLDINGS CORPORATION: Japan's Leading Pharmaceutical Wholesaler
    • 4.5.1. MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2007-2017
    • 4.5.2. Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
    • 4.5.3. MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2018-2028
  • 4.6. Phoenix Group: Biggest European Wholesalers
    • 4.6.1. The PHOENIX Group: Historical Performance, 2011-2015
    • 4.6.2. Future Strategies of the PHOENIX Group: Selective Acquisition
    • 4.6.3. The PHOENIX Group: Revenue Forecast, 2018-2028
  • 4.7. SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
    • 4.7.1. SINOPHARM: Historical Performance, 2011-2017
    • 4.7.2. Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
    • 4.7.3. SINOPHARM: Revenue Forecast, 2018-2028
  • 4.8. Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
    • 4.8.1. Alfresa Holdings: Historical Performance, 2011-2017
    • 4.8.2. Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
    • 4.8.3. Alfresa Holdings: Revenue Forecast, 2018-2028
  • 4.9. SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
    • 4.9.1. SUZUKEN CO. LTD: Historical Performance, 2011-2017
    • 4.9.2. Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
    • 4.9.3. SUZUKEN CO., LTD: Revenue Forecast, 2018-2028
  • 4.10. Shanghai Pharmaceuticals Holding: China's Second Largest Wholesaler
    • 4.10.1. Shanghai Pharmaceuticals Holding: Historical Performance, 2011-2017
    • 4.10.2. Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
    • 4.10.3. Shanghai Pharma: Revenue Forecast, 2018-2028
  • 4.11. Morris & Dickson Co. LLC: Serving More than 175 Years
  • 4.12. H.D. Smith: Largest Independent Wholesaler in the U.S.
    • 4.12.1. H.D. Smith Company History:
    • 4.12.2. H.D. Smith Company Business Strategies
  • 4.13. Smith Drug Company: Serving More than 1400 Customers in U.S.
  • 4.14. Anda Inc.
    • 4.14.1. Segment Overview
    • 4.14.2. Anda Inc. Strategies
  • 4.15. CuraScript Specialty Distribution
    • 4.15.1. Curascript Speciality Distribution Strategies:
  • 4.16. Mawdsley-Brooks & Co. Ltd.
    • 4.16.1. Mawdsley-Brooks & Co Company History:
    • 4.16.2. Mawdsley-Brooks & Co Company Strategies
  • 4.17. North Carolina Mutual Wholesale Drug: 65 years of service
    • 4.17.1. Mutual Wholesale Drug Company History:
    • 4.17.2. Company Strategies
  • 4.18. Prodigy Health
  • 4.19. Fortissa Limited: 20 years of vast experience
  • 4.20. CR Pharmaceutical
    • 4.20.1. Company History
    • 4.20.2. Company Strategies

5. Qualitative Analysis of The Pharma Wholesale and Distribution Market

  • 5.1. The Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2016
    • 5.1.1. The Insatiable Demand for Drugs: A Recession Proof Industry?
    • 5.1.2. Wholesalers Do More than Deliver Drugs
      • 5.1.2.1. Pre-Wholesaling: More Prevalent in Europe
      • 5.1.2.2. Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
    • 5.1.3. Large Companies Dominate the Market
    • 5.1.4. Despite High Revenues, Profit Margins Are Low
    • 5.1.5. Government-Induced Drug Price Pressures Restrict Profits
    • 5.1.6. The Problem of Counterfeit Drugs
  • 5.2. The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2016-2027
    • 5.2.1. The Demand for Pharmaceuticals is Increasing
    • 5.2.2. The Increasing Use of Specialty Drugs Will Drive Growth
    • 5.2.3. The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
    • 5.2.4. The Promotion of Drug Therapy in the US
    • 5.2.5. Globalisation: The Major National Markets are Dominated by Few Companies
    • 5.2.6. Increased Adoption of the DTP Distribution Model
      • 5.2.6.1. DTP in Europe: The First Place the Scheme Has Taken Hold
      • 5.2.6.2. DTP in the UK Since 1991
      • 5.2.6.3. DTP in Poland: The Second European Country to Adopt the DTP Model
      • 5.2.6.4. Further Expansion of the DTP Model
    • 5.2.7. The Threat of Healthcare Budget Cuts
      • 5.2.7.1. Healthcare Budget Cuts in Germany
      • 5.2.7.2. Healthcare Budget Cuts in France
      • 5.2.7.3. Healthcare Budget Cuts in Italy
      • 5.2.7.4. Healthcare Budget Cuts in Spain
      • 5.2.7.5. Healthcare Budget Cuts in the UK
    • 5.2.8. Do Large Pharmacy Chains Pose a Threat?
      • 5.2.8.1. Case Study: Walmart and the $4 Prescription Scheme
      • 5.2.8.2. Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
    • 5.2.9. Does the Diversion and Re-Importation of Medicines Pose a Threat to the Industry?
    • 5.2.10. The Threat of Industry Consolidation
  • 5.3. Social, Technological, Economic and Political Factors Influencing the Market, 2016-2027(STEP Analysis)
    • 5.3.1. Political Factor: The Impact of Recent Regulatory Changes in the EU
    • 5.3.2. Political Factor: Combating Counterfeit Medicines
      • 5.3.2.1. The US and E-Pedigree: Becoming Law in California
      • 5.3.2.2. European Pedigree Legislation
      • 5.3.2.3. Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
      • 5.3.2.4. Serialisation for Wholesalers: Opportunity or a Challenge?

6. Conclusions

  • 6.1. The Future of the Pharma Wholesale and Distribution Market
  • 6.2. The Leading National Pharma Wholesale and Distribution Markets
  • 6.3. The Leading Companies in the Pharma Wholesale and Distribution Industry
  • 6.4. Trends in the Pharma Wholesale and Distribution Industry
    • 6.4.1. Generics Will Threaten Revenue
    • 6.4.2. Manufacturers Will Deliver More Drugs Directly
    • 6.4.3. There Will Be Greater Demand for Specialty Medicines
    • 6.4.4. Consolidation Will Drive Growth
    • 6.4.5. Anti-Counterfeiting Demands Will Add to Wholesalers' Costs
  • Appendices
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 2.1: Use of DTP Model in the UK 2007-2012
  • Table 3.1: Pharmaceutical Wholesale and Distribution: World Market Forecast ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 3.2: Pharmaceutical Wholesale and Distribution: Branded Drugs, Generic Drugs and Others, Revenue ($bn) Forecasts, AGR (%), CAGR (%) and Market Shares (%), 2016-2027
  • Table 3.3: Wholesale and Distribution of Branded Drugs: Revenue ($bn) Forecasts, AGR (%), CAGR (%), 2016-2027
  • Table 3.4: Wholesale and Distribution of Generic Drugs: Revenue ($bn) Forecasts, AGR (%), CAGR (%), 2016-2027
  • Table 4.1: Mckesson, Distribution Solutions: Services and Customers, 2018
  • Table 4.2: Mckesson, Technology Solutions: Services and Customers, 2018
  • Table 4.3: Mckesson: Historical Revenue ($Bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit ($Bn), Gross Profit AGR (%) And Gross Profit CAGR (%), 2007-2017
  • Table 4.4: Mckesson Revenue ($Bn), Revenue Share (%) And AGR (%) Breakdown by Business Segment, 2017-2018
  • Table 4.5: Mckesson: Gross Profit ($Bn), Gross Profit Share (%) and AGR (%) Breakdown by Business Segment, 2017-2018
  • Table 4.6: Acquisitions by Mckesson, 2007-2018
  • Table 4.7: Mckesson: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.8: Mckesson: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.9: Cardinal Health: Historical Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Operating Earnings ($bn), AGR (%) and CAGR (%), 2007-2017
  • Table 4.10: Cardinal Health: Revenue ($Bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.11: Cardinal Health: Operating Earnings ($bn) And Annual Growth (%) Breakdown by Business Segment, 2016-2017
  • Table 4.12: Cardinal Health: Revenue ($bn) And Revenue Share (%) Breakdown by Customer, 2017
  • Table 4.13: Selected Acquisitions by Cardinal Health and their Line of Business, 2007-2017
  • Table 4.14: Cardinal Health: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.15: Cardinal Health: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.16: Amerisourcebergen: Historical Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Operating Income ($bn), Operating Income AGR (%) and Operating Income CAGR (%), 2007-2017
  • Table 4.17: Amerisourcebergen: Revenue ($bn), Revenue Share (%) And AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.18: Amerisourcebergen: Gross Profit ($bn), Gross Profit Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.19: Amerisourcebergen: Revenue ($bn) and Revenue Share (%) Breakdown by Customer, 2017
  • Table 4.20: Acquisitions by AmerisourceBergen and their Line of Business, 2007-2017
  • Table 4.21: Amerisourcebergen: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.22: Amerisourcebergen: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.23: Walgreens Boots Alliance: Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit ($bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2017
  • Table 4.24: Walgreens Boots Alliance: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.25: Walgreens Boots Alliance: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.26: Medipal Holdings: Consolidated Subsidiary Companies, 2016
  • Table 4.27: Medipal Holdings: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit AGR (%), 2007-2017
  • Table 4.28: Medipal Holdings: Revenue (¥bn) And AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.29: Medipal Holdings: Operating Profit (¥bn), And AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.30: Medipal Holdings: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.31: Medipal Holdings: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.32: Phoenix Group: Subsidiary Companies, 2018
  • Table 4.33: Phoenix Group: Historical Revenue (€bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (€bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2017
  • Table 4.34: Phoenix Group: Revenue Share (%) Breakdown by Region, 2016-2017
  • Table 4.35: Phoenix Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.36: Phoenix Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.37: Sinopharm Group: Historical Revenue (RMBbn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (RMBbn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2017
  • Table 4.38: Sinopharm Group: Revenue (RMBbn, $bn) and Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.39: Sinopharm Group: Operating Profit (RMBbn, $bn), Operating Profit Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.40: Sinopharm Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.41: Sinopharm Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.42: Alfresa Holdings: List of Significant Subsidiaries and Affiliates, 2017
  • Table 4.43: Alfresa Holdings: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (¥bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2017
  • Table 4.44: Alfresa Holdings: Business Strategies, 2013-2016
  • Table 4.45: Alfresa Holdings: Revenue (¥bn, $bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.46: Alfresa Holdings: Revenue ($Bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.47: Alfresa Holdings: Revenue ($Bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.48: Suzuken: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (¥bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2017
  • Table 4.49: Suzuken: Revenue (¥bn, $bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.50: Suzuken: Operating Income (¥bn, $bn), Operating Income Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.51: Suzuken: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.52: Suzuken: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.53: Shanghai Pharmaceuticals Holding: Historical Revenue (RMBbn, $bn), Revenue AGR (%), Revenue CAGR (%), 2011-2017
  • Table 4.54: Shanghai Pharmaceuticals Holding: Revenue (RMBbn, $bn), Revenue Share (%) And AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 4.55: Shanghai Pharmaceuticals: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2023
  • Table 4.56: Shanghai Pharmaceuticals: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2023-2028
  • Table 4.57: Morris & Dickson Co. LLC Profile 2018
  • Table 4.58: H.D. Smith Profile 2018
  • Table 4.59: Smith Drug Company Profile 2018
  • Table 4.60: Anda, Inc. Profile 2018
  • Table 4.61: Curascript Specialty Distribution. Profile 2018
  • Table 4.62: Mawdsley-Brooks & Co. Ltd. Profile 2018
  • Table 4.63: North Carolina Mutual Wholesale Drug Profile 2018
  • Table 4.64: Prodigy Health Profile 2018
  • Table 4.65: Fortissa Limited Profile 2018
  • Table 4.66: Cr Pharmaceutical Profile 2018
  • Table 5.1: The Pharmaceutical W&D Market: Strengths and Weaknesses
  • Table 5.2: The Pharmaceutical W&D Market: Opportunities and Threats
  • Table 5.3: Strengths and Weaknesses of The DTP Distribution Model
  • Table 5.4: ITR Ratings and Corresponding Reimbursement Rates, 2016
  • Table 5.5: Social, Technological, Economic and Political Factors Influencing the Pharmaceutical Wholesale and Distribution Market (Step Analysis), 2016-2027

List of Figures

  • Figure 2.1: Routes of Drug Distribution, 2016
  • Figure 3.1: The Global Pharmaceutical Wholesale and Distribution Market: Drivers and Restraints, 2017
  • Figure 3.2: Pharmaceutical Wholesale and Distribution: World Market Forecast ($bn), 2016-2027
  • Figure 3.3: Branded Drugs, Generic Drugs and Others: Market Shares (%), 2016
  • Figure 3.4: Branded Drugs, Generic Drugs and Others: Market Shares (%), 2021
  • Figure 3.5: Branded Drugs, Generic Drugs and Others: Market Shares (%), 2027
  • Figure 3.6: Wholesale and Distribution of Branded Drugs, Generic Drugs and Others: Revenue Forecasts ($bn), 2016-2027
  • Figure 3.7: Wholesale and Distribution of Branded Drugs: Revenue ($bn) Forecast, 2016-2027
  • Figure 3.8: Wholesale and Distribution of Generic Drugs: Revenue ($bn) Forecast, 2016-2027
  • Figure 4.1: Mckesson: Historical Revenue ($bn), Revenue AGR (%), Gross Profit ($bn) And Gross Profit AGR (%), 2007-2017
  • Figure 4.2: Mckesson: Revenue Share (%) Breakdown by Business Segment, 2018
  • Figure 4.3: Mckesson: Gross Profit Share (%) Breakdown by Business Segment, 2018
  • Figure 4.4: Mckesson: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.5: Mckesson: Drivers and Restraints, 2018
  • Figure 4.6: Cardinal Health: Historical Revenue ($Bn), Revenue AGR (%), Operating Earnings ($bn) and Operating Earnings AGR (%), 2010-2015
  • Figure 4.7: Cardinal Health: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.8: Cardinal Health: Revenue Share (%) Breakdown by Customer, 2017
  • Figure 4.9: Cardinal Health: Revenue ($bn) Forecast, 2018-2028
  • Figure 4.10: Cardinal Health: Drivers and Restraints, 2018
  • Figure 4.11: Amerisourcebergen: Historical Revenue ($bn), Revenue AGR (%), Operating Income ($bn) And Operating Income AGR (%), 2007-2017
  • Figure 4.12: Amerisourcebergen: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.13: Amerisourcebergen: Revenue ($bn) Breakdown by Customer, 2017
  • Figure 4.14: Amerisourcebergen: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.15: Amerisourcebergen: Drivers and Restraints, 2018
  • Figure 4.16: Walgreens Boots Alliance: Revenue ($Bn), Revenue AGR (%), Gross Profit ($bn) And Gross Profit AGR (%), 2011-2017
  • Figure 4.17: Walgreens Boots Alliance: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.18: Walgreens Boots Alliance: Drivers and Restraints, 2018
  • Figure 4.19: Medipal Holdings: Historical Revenue (¥Bn), Revenue AGR (%), and Gross Profit AGR (%), 2007-2017
  • Figure 4.20: Medipal Holdings: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.21: Medipal Holdings: Operating Income Share (%) Breakdown by Business Segment, 2017
  • Figure 4.22: Medipal Holdings: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.23: Medipal Holdings: Drivers and Restraints, 2018
  • Figure 4.24: Phoenix Group: Historical Revenue (€Bn), Revenue AGR (%), Gross Profit (€bn) And Gross Profit AGR (%), 2011-2017
  • Figure 4.25: Phoenix Group: Revenue Share (%) Breakdown by Region, 2017
  • Figure 4.26: Phoenix Group: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.27: Phoenix Group Drivers and Restraints, 2018
  • Figure 4.28: Sinopharm Group: Historical Revenue (RMBbn), Revenue AGR (%), Gross Profit (RMBbn) And Gross Profit AGR (%), 2011-2016
  • Figure 4.29: Sinopharm Group: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.30: Sinopharm Group: Drivers and Restraints, 2018
  • Figure 4.31: Alfresa Holdings: Historical Revenue (¥bn), Revenue AGR (%), Gross Profit (¥bn), Gross Profit AGR (%), 2011-2017
  • Figure 4.32: Alfresa Holdings: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.33: Alfresa Holdings: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.34: Alfresa Holdings: Drivers and Restraints, 2018
  • Figure 4.35: Suzuken: Historical Revenue (¥bn), Revenue AGR (%), Gross Profit (¥bn) And Gross Profit AGR (%), 2011-2017
  • Figure 4.36: Suzuken: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.37: Suzuken: Operating Income Share (%) Breakdown by Business Segment, 2017
  • Figure 4.38: Suzuken: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.39: Suzuken: Drivers and Restraints, 2018
  • Figure 4.40: Shanghai Pharmaceuticals Holding: Historical Revenue (RMBbn), Revenue AGR (%), 2011-2017
  • Figure 4.41: Shanghai Pharmaceuticals Holding: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 4.42: Shanghai Pharmaceuticals Holding: Revenue ($bn) Forecast, 2018-2028
  • Figure 4.43: Shanghai Pharmaceuticals Holding: Drivers and Restraints, 2018
  • Figure 5.1: Comparison of The Wholesale and DTP Routes of Distribution, 2016
  • Figure 6.1: Pharmaceutical Wholesale and Distribution: Global Market Forecasts ($bn) By Submarket, 2016-2027
  • Figure 6.2: Leading National Pharmaceutical Wholesale and Distribution Markets: Revenue Projections ($Bn), 2016, 2021 And 2027
  • Figure 6.3: Leading Pharmaceutical Wholesale and Distribution Companies: Revenue ($bn) Projections 2016, 2021 and 2027

COMPANIES LISTED:

  • AB Acquisitions Ltd
  • AbCellera
  • AccessClosure
  • ADG Apotheken-Dienstleistungsgesellschaft mbH
  • Alder BioPharmaceuticals
  • Alfresa Fine Chemical Corporation
  • Alfresa Holdings
  • Alfresa Shinohara Chemicals Corporation
  • Allergan plc
  • Alliance Boots
  • Alliance Santé
  • Alliance UniChem
  • AmeriSource Health
  • AmerisourceBergen
  • Anda, Inc.
  • Apollo Medical Holdings
  • Arete Pharmacy Network
  • AssuraMed Inc.
  • ASTIS Co., Ltd.
  • AstraZeneca
  • ATOL CO., LTD.
  • Azwell
  • Barnes Wholesale Drug Co.
  • Bayer
  • BEID Fund
  • Beijing Pharmaceutical
  • Bellco Health
  • BENU Netherland B.V
  • Biologics Inc.
  • Boots Group
  • Brocacef Holding
  • Cardinal Foods
  • Cardinal Health
  • Cardinal Health China (Yong Yu)
  • Celesio AG
  • Celltrion Healthcare
  • Celltrion, Inc.
  • China Resources Pharmaceutical Group Limited
  • China Resources Saike Pharmaceutical Co.,Ltd.
  • China Resources Zizhu Pharmaceutical Co., Limited
  • Chiyaku Co
  • Chuounyu Co., Ltd.
  • Cloumed Corporation
  • Cordis
  • CoverMyMeds LLC
  • CR Care
  • Crosspharma
  • CuraScript Specialty Distribution
  • CVC Capital Partners
  • CVS Caremark
  • CVS Pharmacy
  • Cystic Fibrosis Foundation Pharmacy
  • Daiichi Sankyo Propharma Co.
  • DE Group
  • DeclaCare B.V.
  • Dierbergs Market
  • Doncaster Pharmaceuticals
  • Dong Ying (Jiangsu) Pharmaceuticals Co., Ltd.
  • Dutch ACM
  • Eclipse Generics
  • Eisai
  • EISEI YAKUHIN CO., LTD.
  • Emart Company
  • Enhanced Service Pharmacy Alliance (ESPhA)
  • ENSHU YAKUHIN CO., LTD.
  • Enturia Inc.
  • Ethicon
  • Eurodrug
  • European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • EVERLTH AGROTECH Co., Ltd.
  • EVERLTH Co., Ltd.
  • Express Scripts Holding Company
  • Farcopa Distribuzione
  • FDC Aomori
  • FDC Hachinohe
  • Fortissa Limited
  • Fujifilm Corporation
  • Fukujin Co.
  • Good Service Co
  • H.D. Smith
  • Harvard Drug
  • Health Institute of China Resources University
  • Healthcare Solutions Holding
  • Healthcare Solutions Holding LLC
  • Hefei Tianmai Biotechnology Development Co. Ltd.
  • HEISEI YAKUHIN CO., LTD.
  • IBM
  • Innomar Strategies Inc.
  • IntrinsiQ LLC
  • IZUTSU KURAYA SANSEIDO Inc
  • IZUTSU PHARMACEUTICAL CO. LTD.
  • J.J. Balan
  • Jingu Yakuhin Co., Ltd.
  • Johnson & Johnson
  • Joseph Brooks Ltd
  • Katz Group
  • Kenzmedico Co., Ltd.
  • Kerr Drug
  • Kinray Inc.
  • KOBASHOU. CO., LTD.
  • Kohlberg Kravis Roberts & Co
  • Kunming Shenghuo Pharmaceutical Group Co.,Ltd.
  • KURAYA CORPORATION
  • KURAYA SANSEIDO Inc
  • Life Medicom Co., Ltd.
  • Liow & Company
  • Lloyds Pharmacy
  • Longs Drugs
  • Luto Research Ltd
  • MARUZEN YAKUHIN CO., LTD.
  • Mawdsley-Brooks & Co. Ltd.
  • MC Healthcare, Inc.
  • McKesson
  • Medicap
  • MEDICEO CORPORATION.
  • Medicine Shoppe
  • MEDIPAL
  • MEDIPAL HOLDINGS CORPORATION
  • Mediq Apotheken Nederland BV
  • Medtronic PLC
  • Meinan Distribution Center
  • Metro Medical Supply Inc.
  • Mitsubishi
  • Mogi Pharmaceutical Co., Ltd.
  • Morris & Dickson Co., LLC
  • MP AGRO CO., LTD.
  • MWI Veterinary Supply, Inc.
  • Mynx Vascular Closure Device (MSD)
  • Nadro
  • Nakano Yakuhin Co., Ltd.
  • National Center for Nanoscience and Technology
  • National Generics
  • NaviHealth
  • NHS
  • Nihon Apoch Co.
  • North Carolina Mutual Wholesale Drug Company
  • Novodata Zrt.
  • Numark
  • Oncoprod
  • Outcomes Incorporated
  • P.J.D. Network
  • PALTAC CORPORATION
  • PALTAC KS CORPORATION
  • Pfercos Co., Ltd.
  • Pfizer International Trading Ltd.
  • PharMEDium Healthcare Holdings
  • PHOENIX Group
  • Polska Grupa Farmaceutyczna
  • Positive Solutions
  • Premier Source
  • Premier, Inc.
  • Procter & Gamble Company
  • Prodigy Health Supplier Corporation
  • Prosper
  • PSC Co, Ltd.
  • PSS World Medical
  • Qol Co., Ltd.
  • Rain Tree Oncology Services
  • RDC Kanto
  • RDC Tohoku
  • Red Oak Sourcing
  • Regeneron Pharmaceuticals, Inc.
  • Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa)
  • Retail Pharmacy USA
  • Rexall Health
  • Rite Aid Corporation
  • Rite Aids
  • Rowlands
  • RxCrossroads
  • S. D.Collabo Co.,Ltd.
  • S.D.Logi CO., Ltd.
  • Sainsbury
  • Sanki Corporation
  • Sanki MediHeart Limited
  • Sanki Wellbe
  • Sanki Wellbe Co., Ltd.
  • Sannova
  • Sanseido Co., Ltd.
  • Sanwa Kagaku Kenkyusho Co., Ltd
  • S-Care Mate
  • S-Care Mate Co., Ltd.
  • Sciclone Trade
  • SEIWA SANGYO CO
  • Shanghai Fosun Pharmaceutical
  • Shanghai Pharma Zhenjiang Co., Ltd.
  • Shanghai Pharmaceutical Holdings
  • Shinohara Chemicals
  • Shinsegai Group
  • Shoyaku Co., Ltd.
  • SINOPHARM
  • Sinopharm Holding Beijing Tianxingpuxin Biomed Co., Ltd.
  • Sinpharm Medicine Holding Beijing Huahong Co., Ltd.
  • S-mile, Inc
  • Smith Drug Company
  • Smith Medical Partners
  • Sonexus Health
  • SPH Jiangxi Shangrao Pharmaceutical Co., Ltd.
  • SPH Keyuan Xinhai Pharmaceutical Hebei Co., Ltd.
  • SPH Keyuan Xinhai Pharmaceutical Heilongjiang Co., Ltd.
  • St. Francis Group
  • SUNPHARMA
  • SUZUKEN CO., LTD.
  • Suzuken Iwate Co., Ltd.
  • Suzuken Medical Instruments Co, Ltd
  • Suzuken Okinawa Yakuhin Co., Ltd.
  • Takeda
  • Teva Pharmaceutical Industries Limited
  • Teva Takeda Yakuhin Ltd.
  • TheraCom LLC
  • Toho Holdings
  • Tokiwa Yakuhin Co.
  • TOKYO PHARMACEUTICAL Co., Ltd
  • Torfarm
  • Tradex International
  • Triplefin
  • TS Alfresa Corporation
  • Uni-Bio Science Group Limited.
  • UniChem
  • US Oncology Holdings, Inc.
  • USHIODA KURAYA SANSEIDO Inc.
  • USHIODA SANGOKUDO YAKUHIN CO., LTD.
  • Valley Wholesale Drug Co. Inc.,
  • Vantage Oncology
  • VIA SYS Healthcare Inc.
  • Vizient Inc.
  • Walgreen
  • Walgreens Boots Alliance
  • Walmart
  • World Courier Group Co.
  • World Courier Group Inc.
  • Wuhan Chopper Biology
  • WuXi AppTec
  • Xcenda LLC
  • Yakuju Corporation
  • YAMAHIRO KURAYA SANSEIDO Inc.
  • Yong Yu
  • Yunnan Pharmaceutical Co., Ltd.
  • Zuellig Pharma
Back to Top